Lohman Technologies Welcomes Accomplished Healthcare Innovator Dr Nick Turkal to its Board of Directors

Dr. Nick Turkal joins Lohman’s Board of Directors, strengthening leadership in the remote cardiac care solution company.

Lohman Technologies proudly announces the appointment of Dr. Nick Turkal to its esteemed Board of Directors. This strategic addition reinforces Lohman’s commitment to advancing innovation, driving growth, and shaping the future of remote cardiac monitoring solutions.

With an illustrious career spanning 30 years, Dr Nick Turkal brings a wealth of expertise and a proven track record in the healthcare industry. Dr. Turkal’s visionary leadership, combined with a deep understanding of the dynamic healthcare landscape will contribute significantly to Lohman’s ongoing success.

“We are thrilled to welcome Dr. Turkal to our board,” said Jason Dvorak, President of Lohman Technologies. “His extensive experience and on-going passion for improving access for all patients aligns seamlessly with our mission to continuously improve and impact the care continuum through innovative remote cardiac monitoring, collaborative partnerships, and the promotion of health equity. Dr. Turkal will play a pivotal role in guiding our company.”

In addition to serving Lohman Technologies as a Board Member, Dr, Turkal serves as Chief Medical Advisor to Lohman and sits on the Board of the Crisis Prevention Institute (CPI). He is also past Chair of the Wisconsin Hospital Association Board and served on the Boards of Blood Center of Wisconsin, StartUp Health, abouthealth, Premier and the Greater Milwaukee Committee, MMAC, United Way, American Hospital Association Governing Council, numerous academic institutions, including Creighton University, Burrell College of Osteopathic Medicine, and Idaho College of Osteopathic Medicine. Turkal also served as a Board member for Advocate Aurora Health while CEO.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.